Neurocrine Biosciences Inc (STU:NB3)
€ 153.15 -1.9 (-1.23%) Market Cap: 15.37 Bil Enterprise Value: 14.57 Bil PE Ratio: 26.83 PB Ratio: 5.14 GF Score: 93/100

Neurocrine Biosciences Inc at Leerink Global Healthcare Conference Transcript

Mar 09, 2026 / 12:40PM GMT
Release Date Price: €111.75 (+1.78%)
Marc Goodman
Leerink Partners LLC - Analyst

Thank you very much for joining us. Matt, I'll give you a chance just to make an opening comment maybe not too long, but just kind of set the stage.

Matthew Abernethy
Neurocrine Biosciences Inc - Chief Financial Officer

I'll try to run out the clock if that's okay. And we'll pivot a little bit throughout this presentation. How about that, Marc? We will be making forward-looking statements. So we'll direct you to our latest SEC filings for the related risk factors and uncertainties associated with our company and then also our industry.

Now that we have that fun fact behind us, we're at a great spot, Marc. We had -- how long was that dinner last night? About two hours?

Marc Goodman
Leerink Partners LLC - Analyst

Yeah, because they didn't serve the food very quickly.

Matthew Abernethy
Neurocrine Biosciences Inc - Chief Financial Officer

They were still catching the salmon. But to be at a spot where you have 2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot